Clinical Trial

Ketamine Biomarker Validation

Name: Ketamine Biomarker Validation — clinical trial record (NCT07307768)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

We will be developing an EEG-based biomarker for the effects of ketamine infusion in patients with Depression. We will be analyzing the effects of ketamine infusion on Depression symptoms and EEG signals.

Trial Details

NCT Number	NCT07307768
Lead Sponsor	Soterix Medical Collaborators: Columbia University
Conditions	Treatment Resistant Depression (TRD)
Enrollment	20 participants
Start Date	2025-12-20
Primary Completion	2027-12-01 (estimated)
Study Completion	2028-03-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-29